These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 609363)

  • 1. The effect of long-term chlorthalidone on stone formation and stone growth, intestinal absorption of calcium and secretion of parathyroid hormone in idiopathic hypercalciuria.
    Lockefeer JH; Juttmann JR; Birkenhäger JC
    Neth J Med; 1977; 20(6):257-62. PubMed ID: 609363
    [No Abstract]   [Full Text] [Related]  

  • 2. Oxalate metabolism in renal stone disease with special reference to calcium metabolism and intestinal absorption.
    Lindsjö M
    Scand J Urol Nephrol Suppl; 1989; 119():1-53. PubMed ID: 2669121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pathogenesis of idiopathic hypercalciuria: evidence for parathyroid hyperfunction.
    Evans RA; Hills E; Wong SY; Wyndham LE; Eade Y; Dunstan CR
    Q J Med; 1984; 53(209):41-53. PubMed ID: 6324269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of diuretics on renal and intestinal handling of calcium.
    Gursel E
    N Y State J Med; 1970 Feb; 70(3):399-405. PubMed ID: 5262240
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on intestinal calcium absorption in patients with idiopathic hypercalciuria.
    Duncombe VM; Watts RW; Peters TJ
    Q J Med; 1984; 53(209):69-79. PubMed ID: 6546801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Idiopathic hypercalciuria. A state of compensated hyperparathyroidism?
    Liberman UA; De Vries A
    Rev Eur Etud Clin Biol; 1971 Nov; 16(9):860-5. PubMed ID: 4945963
    [No Abstract]   [Full Text] [Related]  

  • 7. Successful treatment of recurrent nephrolithiasis (calcium stones) with cellulose phosphate.
    Pak CY; Delea CS; Bartter FC
    N Engl J Med; 1974 Jan; 290(4):175-80. PubMed ID: 4808916
    [No Abstract]   [Full Text] [Related]  

  • 8. [Diuretic treatment of recurrent nephrolithiasis caused by idiopathic hypercalciuria].
    Birkenhäger JC; Lockefeer J; Bakker NJ
    Ned Tijdschr Geneeskd; 1972 Aug; 116(33):1485-6. PubMed ID: 5069838
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of bendroflumethiazide on the intestinal absorption of calcium in normocalcaemic renal stone formers and in hyperparathyroidism.
    Jorgensen FS; Transbol I
    Acta Med Scand; 1974; 195(1-2):33-6. PubMed ID: 4817089
    [No Abstract]   [Full Text] [Related]  

  • 10. Calcium metabolism in renal stone disease.
    Ljunghall S; Backman U; Danielson BG; Fellström B; Johansson G; Wikström B
    Scand J Urol Nephrol Suppl; 1980; 53():111-23. PubMed ID: 6937987
    [No Abstract]   [Full Text] [Related]  

  • 11. Absence of secondary hyperparathyroidism in most patients with renal hypercalciuria.
    Olmer M; Berland Y; Argemi B
    Kidney Int Suppl; 1983 Dec; 16():S175-9. PubMed ID: 6330424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hypercalciuria and kidney calculi].
    Netelenbos JC; Haagsma-Schouten WA; Lopes Cardozo E
    Ned Tijdschr Geneeskd; 1978 Dec; 122(51):2020-5. PubMed ID: 723991
    [No Abstract]   [Full Text] [Related]  

  • 13. [Idiopathic hypercalciuria--recent pathogenetic and diagnostic aspects].
    Hess B; Binswanger U
    Schweiz Med Wochenschr; 1986 Nov; 116(45):1569-75. PubMed ID: 3538383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chlorthalidone promotes mineral retention in patients with idiopathic hypercalciuria.
    Coe FL; Parks JH; Bushinsky DA; Langman CB; Favus MJ
    Kidney Int; 1988 Jun; 33(6):1140-6. PubMed ID: 3404813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hydrochlorothiazide and chlorthalidone in the treatment of patients with calcium-phosphate disorders].
    Sawicki A; Soszyński P
    Pol Tyg Lek; 1984 Jul 16-23; 39(29-30):993-7. PubMed ID: 6504725
    [No Abstract]   [Full Text] [Related]  

  • 16. Pathogenesis and management of hypercalciuric nephrolithiasis.
    Breslau NA
    Miner Electrolyte Metab; 1994; 20(6):328-39. PubMed ID: 7783695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphate metabolism and renal calcium stone disease.
    Wikström B
    Scand J Urol Nephrol Suppl; 1981; 61():1-56. PubMed ID: 6274003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gain-of-function haplotype in the epithelial calcium channel TRPV6 is a risk factor for renal calcium stone formation.
    Suzuki Y; Pasch A; Bonny O; Mohaupt MG; Hediger MA; Frey FJ
    Hum Mol Genet; 2008 Jun; 17(11):1613-8. PubMed ID: 18276610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Responsiveness of hypercalciuria to thiazide in Dent's disease.
    Raja KA; Schurman S; D'mello RG; Blowey D; Goodyer P; Van Why S; Ploutz-Snyder RJ; Asplin J; Scheinman SJ
    J Am Soc Nephrol; 2002 Dec; 13(12):2938-44. PubMed ID: 12444212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of oral calcium loading on intact PTH and calcitriol in idiopathic renal calcium stone formers and healthy controls.
    Hess B; Lippuner K; Takkinen R; Villiger L; Ackermann D; Jaeger P
    Nephrol Dial Transplant; 1995; 10(9):1614-9. PubMed ID: 8559479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.